On using machine learning algorithms to define clinically meaningful patient subgroups.

Journal: Annals of the rheumatic diseases
Published Date: Oct 1, 2020

Abstract

No abstract available for this article.

Authors

  • Iago Pinal-Fernandez
    Muscle Disease Unit, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Laboratory of Muscle Stem Cells and Gene Expression, Bethesda, Maryland, USA pinalfernandei@nih.gov andrew.mammen@nih.gov.
  • Andrew Lee Mammen
    Muscle Disease Unit, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Laboratory of Muscle Stem Cells and Gene Expression, Bethesda, Maryland, USA pinalfernandei@nih.gov andrew.mammen@nih.gov.

Keywords

External Resources

Popular Topics
Recent Journals